Skip to content

Visual Adaptation and Quality of Life After Different IOL Implantation Strategies

Evaluation of Visual Adaptation and Optical Performance in Patients With Bilateral Multifocal or Mix-and-Match Intraocular Lens Implantation: A Longitudinal Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07740590
Acronym
MMAQ-IOL
Enrollment
264
Registered
2026-07-31
Start date
2025-03-01
Completion date
2027-12-31
Last updated
2026-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphakia - Lens Capsule Present, Cataract

Keywords

Intraocular Lenses, Multifocal Intraocular Lenses, Neuroadaptation, Visual Performance, Quality of Life

Brief summary

This longitudinal observational study aims to evaluate long-term visual adaptation trajectories, optical quality, and patient-reported outcomes in age-related cataract patients following bilateral implantation of multifocal or mix-and-match intraocular lenses (IOLs). Patients will be followed up longitudinally after surgery to systematically assess visual performance and quality of life.

Detailed description

Multifocal and mix-and-match intraocular lens (IOL) implantation strategies have been widely adopted to restore full-range vision after cataract surgery. However, patients often experience varying rates and trajectories of neuroadaptation to optical phenomena such as glare and halos. This study prospectively observational tracks age-related cataract patients undergoing bilateral IOL implantation (homogeneous or mix-and-match combinations). Postoperative evaluations are systematically conducted across key follow-up time points (ranging from 1 week up to 6 months postoperatively). Primary evaluations involve standard ophthalmological measurements alongside validated visual questionnaires (including the MMAQ) to capture longitudinal adaptation patterns, spectacle independence, and overall visual satisfaction.

Interventions

DEVICEBilateral Bifocal IOL Implantation

Bilateral phacoemulsification with bifocal intraocular lens implantation in both eyes.

DEVICEBifocal and EDOF IOL Mix-and-Match Implantation

Bilateral phacoemulsification with bifocal intraocular lens implantation in one eye and EDOF intraocular lens implantation in the contralateral eye.

DEVICEBifocal and Monofocal IOL Mix-and-Match Implantation

Bilateral phacoemulsification with bifocal intraocular lens implantation in one eye and monofocal intraocular lens implantation in the contralateral eye.

Sponsors

Sichuan Academy of Medical Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older with age-related cataract requiring bilateral phacoemulsification and intraocular lens (IOL) implantation * Corneal astigmatism less than 0.75 D * Good general health and willing to complete all postoperative follow-up visits * Signed written informed consent

Exclusion criteria

* Previous ocular surgery or ocular trauma * Coexisting ocular diseases affecting visual potential, such as corneal opacity, glaucoma, macular degeneration, or diabetic retinopathy * Intraoperative or postoperative complications (e.g., posterior capsule rupture) * Systemic diseases that may interfere with visual outcomes or follow-up compliance

Design outcomes

Primary

MeasureTime frameDescription
Subjective Visual Adaptation Score (Multifocal Motor Adaptation Questionnaire, MMAQ)Preoperatively, and postoperatively at 1 week, 1 month, 3 months, and 6 monthsAssessed using the Multifocal Motor Adaptation Questionnaire (MMAQ), a custom-designed questionnaire developed by the research team to measure subjective visual adaptation and symptoms in patients following intraocular lens implantation. Scores range from 0 to 100, with higher scores indicating higher levels of visual adaptation and satisfaction.

Secondary

MeasureTime frameDescription
Total High-Order Aberrations (HOAs)Postoperatively at 1 month, 3 months, and 6 monthsChange in total high-order aberrations (3rd to 6th order RMS, measured in micrometers) from baseline to 1 month, 3 months, and 6 months postoperatively, evaluated using an ocular/corneal wavefront aberrometer under a standardized pupil diameter (e.g., 4.0 mm / 6.0 mm).
Defocus CurvePostoperatively at 1 month, 3 months, and 6 monthsVisual acuity evaluated at varying lens powers ranging from +1.50 D to -4.00 D in 0.50 D steps to assess the range of clear vision
Uncorrected Binocular Distance Visual Acuity (UDBVA)Preoperatively, and postoperatively at ,1 month, 3 months, and 6 monthsChange in uncorrected binocular distance visual acuity measured at 4 meters under photopic lighting conditions using standard Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity charts. Lower LogMAR values indicate superior visual acuity.
Spherical AberrationPostoperative 1 month, 3 months, and 6 monthsChange in spherical aberration ( Zernike coefficient, measured in micrometers) from baseline to 1 month, 3 months, and 6 months postoperatively, evaluated using an ocular/corneal wavefront aberrometer under a standardized pupil diameter (e.g., 4.0 mm / 6.0 mm).
Horizontal ComaPostoperative 1 month, 3 months, and 6 monthsChange in horizontal coma ( Zernike coefficient, measured in micrometers) from baseline to 1 month, 3 months, and 6 months postoperatively, evaluated using an ocular/corneal wavefront aberrometer under a standardized pupil diameter (e.g., 4.0 mm / 6.0 mm).
Vertical ComaPostoperative 1 month, 3 months, and 6 monthsChange in vertical coma Zernike coefficient, measured in micrometers) from baseline to 1 month, 3 months, and 6 months postoperatively, evaluated using an ocular/corneal wavefront aberrometer under a standardized pupil diameter (e.g., 4.0 mm / 6.0 mm).
Total Coma RMSPostoperative 1 month, 3 months, and 6 monthsChange in total coma measured in micrometers) from baseline to 1 month, 3 months, and 6 months postoperatively, evaluated using an ocular/corneal wavefront aberrometer under a standardized pupil diameter (e.g., 4.0 mm / 6.0 mm).
Uncorrected Binocular Intermediate Visual Acuity (UIBVA)Preoperatively, and postoperatively at 1 month, 3 months, and 6 monthsChange in uncorrected binocular intermediate visual acuity measured at 80 cm (and/or 66 cm) under photopic lighting conditions using standard Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity charts. Lower LogMAR values indicate superior visual acuity.
Uncorrected Bincorrected Near Visual Acuity (UNBVA)Preoperatively, and postoperatively at 1 month, 3 months, and 6 monthsChange in uncorrected binocular near visual acuity measured at 40 cm under photopic lighting conditions ($85\\ \\text{cd/m}\^2$) using standard Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity charts. Lower LogMAR values indicate superior visual acuity.
Contrast SensitivityPostoperative 1 month, 3 months, and 6 monthsChange in contrast sensitivity (logarithmic values) across standardized spatial frequencies (1.5, 3, 6, 12, and 18 cycles per degree) from baseline to 1 month, 3 months, and 6 months postoperatively. Evaluated using a standardized contrast sensitivity chart (e.g., CSV-1000 or Optec 6500) under both photopic and mesopic lighting conditions (with and without glare).

Countries

China

Contacts

CONTACTXiangjun Fu, Ph.D.
243981469@qq.com+86-28-87393999
PRINCIPAL_INVESTIGATORChao Qu

School of Medicine, University of Electronic Science and Technology of China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026